Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis

Cell Host and Microbe

Volumn 25, Issue 2, 2019, Pages 285-299.e8

  Gogokhia, Lasha ^a,b   Buhrke, Kate ^a   Bell, Rickesha ^a   Hoffman, Brenden ^a   Brown, D Garrett ^a   Hanke Gogokhia, Christin ^a   Ajami, Nadim J ^c   Wong, Matthew C ^c   Ghazaryan, Arevik ^a   Valentine, John F ^a   Porter, Nathan ^d   Martens, Eric ^d   O'Connell, Ryan ^a   Jacob, Vinita ^b   Scherl, Ellen ^b   Crawford, Carl ^b   Stephens, W Zac ^a   Casjens, Sherwood R ^a   Longman, Randy S ^b   Round, June L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

bacteriophages; colitis; dendritic cells; FMT; IFN y; T cells; Th1; TLR9

Indexed keywords

BACTERIOPHAGE DNA; GAMMA INTERFERON; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIOPHAGE; BACTEROIDES; CELL EXPANSION; COLITIS; COMMUNITY DYNAMICS; CONTROLLED STUDY; DISEASE EXACERBATION; ENTERITIS; ESCHERICHIA; FECAL MICROBIOTA TRANSPLANTATION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INTERFERON PRODUCTION; INTESTINE FLORA; LACTOBACILLUS; MALE; MICROBIAL COMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; ULCERATIVE COLITIS; ANIMAL; BACTERIUM; C57BL MOUSE; CD4+ T LYMPHOCYTE; COLORECTAL TUMOR; DISEASE MODEL; GERMFREE ANIMAL; HUMAN; IMMUNOLOGY; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; PATHOLOGY; PILOT STUDY; PROSPECTIVE STUDY; VIROLOGY;

ANIMALS; BACTERIA; BACTERIOPHAGES; CD4-POSITIVE T-LYMPHOCYTES; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; FECAL MICROBIOTA TRANSPLANTATION; GASTROINTESTINAL MICROBIOME; HUMANS; INTERFERON-GAMMA; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PILOT PROJECTS; PROSPECTIVE STUDIES; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 85060769201     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2019.01.008     Document Type: Article

References (63)

1. Ajami, N.J., Wong, M.C., Ross, M.C., Lloyd, R.E., Petrosino, J.F., Maximal viral information recovery from sequence data using VirMAP. Nat. Commun., 9, 2018, 3205.
2. Arthur, J.C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J.M., Fan, T.J., Campbell, B.J., Abujamel, T., Dogan, B., Rogers, A.B., et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338 (2012), 120–123.
3. Barker, N., Ridgway, R.A., van Es, J.H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A.R., Sansom, O.J., Clevers, H., Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457 (2009), 608–611.
4. Barr, J.J., Auro, R., Furlan, M., Whiteson, K.L., Erb, M.L., Pogliano, J., Stotland, A., Wolkowicz, R., Cutting, A.S., Doran, K.S., et al. Bacteriophage adhering to mucus provide a non-host-derived immunity. Proc. Natl. Acad. Sci. U S A 110 (2013), 10771–10776.
5. Bauer, D.W., Li, D., Huffman, J., Homa, F.L., Wilson, K., Leavitt, J.C., Casjens, S.R., Baines, J., Evilevitch, A., Exploring the balance between DNA pressure and capsid stability in herpesviruses and phages. J. Virol. 89 (2015), 9288–9298.
6. Belkaid, Y., Hand, T.W., Role of the microbiota in immunity and inflammation. Cell 157 (2014), 121–141.
7. Bragg, R., van der Westhuizen, W., Lee, J.Y., Coetsee, E., Boucher, C., Bacteriophages as potential treatment option for antibiotic resistant bacteria. Adv. Exp. Med. Biol. 807 (2014), 97–110.
8. Breitbart, M., Hewson, I., Felts, B., Mahaffy, J.M., Nulton, J., Salamon, P., Rohwer, F., Metagenomic analyses of an uncultured viral community from human feces. J. Bacteriol. 185 (2003), 6220–6223.
9. Cadwell, K., The virome in host health and disease. Immunity 42 (2015), 805–813.
10. Chadha, P., Katare, O.P., Chhibber, S., In vivo efficacy of single phage versus phage cocktail in resolving burn wound infection in BALB/c mice. Microb. Pathog. 99 (2016), 68–77.
11. Dabrowska, K., Switała-Jelen, K., Opolski, A., Weber-Dabrowska, B., Gorski, A., Bacteriophage penetration in vertebrates. J. Appl. Microbiol. 98 (2005), 7–13.
12. Dejea, C.M., Fathi, P., Craig, J.M., Boleij, A., Taddese, R., Geis, A.L., Wu, X., DeStefano Shields, C.E., Hechenbleikner, E.M., Huso, D.L., et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science 359 (2018), 592–597.
13. Dobrovolskaia, M.A., Vogel, S.N., Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect. 4 (2002), 903–914.
14. Duerkop, B.A., Hooper, L.V., Resident viruses and their interactions with the immune system. Nat. Immunol. 14 (2013), 654–659.
15. Duerkop, B.A., Kleiner, M., Paez-Espino, D., Zhu, W., Bushnell, B., Hassell, B., Winter, S.E., Kyrpides, N.C., Hooper, L.V., Murine colitis reveals a disease-associated bacteriophage community. Nat. Microbiol. 3 (2018), 1023–1031.
16. Duerr, D.M., White, S.J., Schluesener, H.J., Identification of peptide sequences that induce the transport of phage across the gastrointestinal mucosal barrier. J. Virol. Methods 116 (2004), 177–180.
17. Eriksson, F., Tsagozis, P., Lundberg, K., Parsa, R., Mangsbo, S.M., Persson, M.A., Harris, R.A., Pisa, P., Tumor-specific bacteriophages induce tumor destruction through activation of tumor-associated macrophages. J. Immunol. 182 (2009), 3105–3111.
18. Frank, D.N., St Amand, A.L., Feldman, R.A., Boedeker, E.C., Harpaz, N., Pace, N.R., Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U S A 104 (2007), 13780–13785.
19. Gensollen, T., Iyer, S.S., Kasper, D.L., Blumberg, R.S., How colonization by microbiota in early life shapes the immune system. Science 352 (2016), 539–544.
20. Gevers, D., Kugathasan, S., Denson, L.A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., Schwager, E., Knights, D., Song, S.J., Yassour, M., et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15 (2014), 382–392.
21. Górski, A., Międzybrodzki, R., Borysowski, J., Dąbrowska, K., Wierzbicki, P., Ohams, M., Korczak-Kowalska, G., Olszowska-Zaremba, N., Łusiak-Szelachowska, M., Kłak, M., et al. Phage as a modulator of immune responses: practical implications for phage therapy. Adv. Virus Res. 83 (2012), 41–71.
22. Grose, J.H., Casjens, S.R., Understanding the enormous diversity of bacteriophages: the tailed phages that infect the bacterial family Enterobacteriaceae. Virology 468–470 (2014), 421–443.
23. Harberts, E., Gaspari, A.A., TLR signaling and DNA repair: are they associated?. J. Invest. Dermatol. 133 (2013), 296–302.
24. Hecker, W., Witthauer, D., Staerk, A., Validation of dry heat inactivation of bacterial endotoxins. PDA J. Pharm. Sci. Technol. 48 (1994), 197–204.
25. Hodyra-Stefaniak, K., Miernikiewicz, P., Drapala, J., Drab, M., Jonczyk-Matysiak, E., Lecion, D., Kazmierczak, Z., Beta, W., Majewska, J., et al. Mammalian host-versus-phage immune response determines phage fate in vivo. Sci. Rep., 5, 2015, 14802.
26. Jacob, V., Crawford, C., Cohen-Mekelburg, S., Viladomiu, M., Putzel, G.G., Schneider, Y., Chabouni, F., O'Neil, S., Bosworth, B., Woo, V., et al. Single delivery of high-diversity fecal microbiota preparation by colonoscopy is safe and effective in increasing microbial diversity in active ulcerative colitis. Inflamm. Bowel Dis. 23 (2017), 903–911.
27. Kawai, T., Akira, S., Toll-like receptor and RIG-I-like receptor signaling. Ann. N Y Acad. Sci. 1143 (2008), 1–20.
28. Kernbauer, E., Ding, Y., Cadwell, K., An enteric virus can replace the beneficial function of commensal bacteria. Nature 516 (2014), 94–98.
29. Khan Mirzaei, M., Eriksson, H., Kasuga, K., Haggård-Ljungquist, E., Nilsson, A.S., Genomic, proteomic, morphological, and phylogenetic analyses of vB_EcoP_SU10, a Podoviridae phage with C3 morphology. PLoS One, 9, 2014, e116294.
30. Kostic, A.D., Chun, E., Robertson, L., Glickman, J.N., Gallini, C.A., Michaud, M., Clancy, T.E., Chung, D.C., Lochhead, P., Hold, G.L., et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14 (2013), 207–215.
31. Kubinak, J.L., Petersen, C., Stephens, W.Z., Soto, R., Bake, E., O'Connell, R.M., Round, J.L., MyD88 signaling in T cells directs IgA-mediated control of the microbiota to promote health. Cell Host Microbe 17 (2015), 153–163.
32. Krumsiek, J., Arnold, R., Rattei, T., Gepard: A rapid and sensitive tool for creating dotplots on genome scale. Bioinformatics 23 (2007), 1026–1028.
33. Kurzepa, A., Dabrowska, K., Skaradziński, G., Górski, A., Bacteriophage interactions with phagocytes and their potential significance in experimental therapy. Clin. Exp. Med. 9 (2009), 93–100.
34. Kutter, E., De Vos, D., Gvasalia, G., Alavidze, Z., Gogokhia, L., Kuhl, S., Abedon, S.T., Phage therapy in clinical practice: treatment of human infections. Curr. Pharm. Biotechnol. 11 (2010), 69–86.
35. Lepage, P., Colombet, J., Marteau, P., Sime-Ngando, T., Doré J., Leclerc, M., Dysbiosis in inflammatory bowel disease: a role for bacteriophages?. Gut 57 (2008), 424–425.
36. Levy, M., Kolodziejczyk, A.A., Thaiss, C.A., Elinav, E., Dysbiosis and the immune system. Nat. Rev. Immunol. 17 (2017), 219–232.
37. Manichanh, C., Borruel, N., Casellas, F., Guarner, F., The gut microbiota in IBD. Nat. Rev. Gastroenterol. Hepatol. 9 (2012), 599–608.
38. Mazmanian, S.K., Liu, C.H., Tzianabos, A.O., Kasper, D.L., An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122 (2005), 107–118.
39. Medzhitov, R., Janeway, C. Jr., The Toll receptor family and microbial recognition. Trends Microbiol. 8 (2000), 452–456.
40. Miernikiewicz, P., Dąbrowska, K., Piotrowicz, A., Owczarek, B., Wojas-Turek, J., Kicielińska, J., Rossowska, J., Pajtasz-Piasecka, E., Hodyra, K., Macegoniuk, K., et al. T4 phage and its head surface proteins do not stimulate inflammatory mediator production. PLoS One, 8, 2013, e71036.
41. Mills, S., Shanahan, F., Stanton, C., Hill, C., Coffey, A., Ross, R.P., Movers and shakers: influence of bacteriophages in shaping the mammalian gut microbiota. Gut Microbes 4 (2013), 4–16.
42. Moayyedi, P., Surette, M.G., Kim, P.T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J.K., Kassam, Z., Reinisch, W., et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149 (2015), 102–109.
43. Moustafa, A., Xie, C., Kirkness, E., Biggs, W., Wong, E., Turpaz, Y., Bloom, K., Delwart, E., Nelson, K.E., Venter, J.C., et al. The blood DNA virome in 8,000 humans. PLoS Pathog., 13, 2017, e1006292.
44. Nguyen, S., Baker, K., Padman, B.S., Patwa, R., Dunstan, R.A., Weston, T.A., Schlosser, K., Bailey, B., Lithgow, T., Lazarou, M., et al. Bacteriophage transcytosis provides a mechanism to cross epithelial cell layers. MBio, 8, 2017, 10.1128/mBio.01874-17.
45. Nho, S.W., Ha, M.A., Kim, K.S., Kim, T.H., Jang, H.B., Cha, I.S., Park, S.B., Kim, Y.K., Jung, T.S., Complete genome sequence of the bacteriophages ECBP1 and ECBP2 isolated from two different Escherichia coli strains. J. Virol 86 (2012), 12439–12440.
46. Norman, J.M., Handley, S.A., Baldridge, M.T., Droit, L., Liu, C.Y., Keller, B.C., Kambal, A., Monaco, C.L., Zhao, G., Fleshner, P., et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160 (2015), 447–460.
47. Palm, N.W., de Zoete, M.R., Cullen, T.W., Barry, N.A., Stefanowski, J., Hao, L., Degnan, P.H., Hu, J., Peter, I., Zhang, W., et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 158 (2014), 1000–1010.
48. Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Granucci, F., Kraehenbuhl, J.P., Ricciardi-Castagnoli, P., Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol 2 (2001), 361–367.
49. Reyes, A., Haynes, M., Hanson, N., Angly, F.E., Heath, A.C., Rohwer, F., Gordon, J.I., Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 466 (2010), 334–338.
50. Roach, D.R., Leung, C.Y., Henry, M., Morello, E., Singh, D., Di Santo, J.P., Weitz, J.S., Debarbieux, L., Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen. Cell Host Microbe 22 (2017), 38–47.
51. Round, J.L., Lee, S.M., Li, J., Tran, G., Jabri, B., Chatila, T.A., Mazmanian, S.K., The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332 (2011), 974–977.
52. Round, J.L., Mazmanian, S.K., Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. USA 107 (2010), 12204–12209.
53. Rubinstein, M.R., Wang, X., Liu, W., Hao, Y., Cai, G., Han, Y.W., Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 14 (2013), 195–206.
54. Savalia, D., Westblade, L.F., Goel, M., Florens, L., Kemp, P., Akulenko, N., Pavlova, O., Padovan, J.C., Chait, B.T., Washburn, M.P., et al. Genomic and proteomic analysis of phiEco32, a novel Escherichia coli bacteriophage. J. Mol. Biol. 377 (2008), 774–789.
55. Sokol, H., Leducq, V., Aschard, H., Pham, H.P., Jegou, S., Landman, C., Cohen, D., Liguori, G., Bourrier, A., Nion-Larmurier, I., et al. Fungal microbiota dysbiosis in IBD. Gut 66 (2017), 1039–1048.
56. Suttle, C.A., Viruses in the sea. Nature 437 (2005), 356–361.
57. Szermer-Olearnik, B., Boratyński, J., Removal of endotoxins from bacteriophage preparations by extraction with organic solvents. PLoS One, 10, 2015, e0122672.
58. Tetz, G.V., Ruggles, K.V., Zhou, H., Heguy, A., Tsirigos, A., Tetz, V., Bacteriophages as potential new mammalian pathogens. Sci. Rep, 7, 2017, 7043.
59. Tsonos, J., Vandenheuvel, D., Briers, Y., De Greve, H., Hernalsteens, J.P., Lavigne, R., Hurdles in bacteriophage therapy: deconstructing the parameters. Vet. Microbiol. 171 (2014), 460–469.
60. Vermeire, S., Van Assche, G., Rutgeerts, P., Inflammatory bowel disease and colitis: new concepts from the bench and the clinic. Curr. Opin. Gastroenterol 27 (2011), 32–37.
61. Virgin, H.W., The virome in mammalian physiology and disease. Cell 157 (2014), 142–150.
62. Wagner, J., Maksimovic, J., Farries, G., Sim, W.H., Bishop, R.F., Cameron, D.J., Catto-Smith, A.G., Kirkwood, C.D., Bacteriophages in gut samples from pediatric Crohn's disease patients: metagenomic analysis using 454 pyrosequencing. Inflamm. Bowel Dis 19 (2013), 1598–1608.
63. Winter, S.E., Winter, M.G., Xavier, M.N., Thiennimitr, P., Poon, V., Keestra, A.M., Laughlin, R.C., Gomez, G., Wu, J., Lawhon, S.D., et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 339 (2013), 708–711.